Genetic polymorphisms of innate immunity in adult patients with bronchial asthma


Cite item

Full Text

Abstract

.

About the authors

L Yu Barycheva

FGBO VO «Stavropol state medical university» Health Ministry of Russian Federation

Author for correspondence.
Email: info@rusalljournal.ru
Stavropol, Russia

L V Shushanova

FGBO VO «Stavropol state medical university» Health Ministry of Russian Federation

Email: info@rusalljournal.ru
Stavropol, Russia

E S Kuzmina

FGBO VO «Stavropol state medical university» Health Ministry of Russian Federation

Email: info@rusalljournal.ru
Stavropol, Russia

Ju N Medvedenko

FGBO VO «Stavropol state medical university» Health Ministry of Russian Federation

Email: info@rusalljournal.ru
Stavropol, Russia

References

  1. Alexis N. E. Biomarker sampling of the airways in asthma. Curr. Opin. Pulm. Med. 2014;20(1):46-52. https:/ doi: 10.1097/MCP. 0000000000000010
  2. Maisonneuve C., Bertholet S., Philpott D. J., De Gregorio E. Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants. Proc. Sci. 2014;111(34):12294-12299. https:/doi:10.1073/ pnas.1400478111
  3. Sathish V., Thompson M. A., Sinha S., Sieck G. C. Prakash Y. S., Pabelick C. M. Inflammation, caveolae and CD38-mediated calcium regulation in human airway smooth muscle // Biochim. Biophys Acta. 2014;1843(2): 346-351. https://doi.org/10.1016/j.bbamcr.2013.11.011
  4. Koponen P., Vuononvirta J., Nuolivirta K., Helminen M., He Q., Korppi M. The association of genetic variants in toll-like receptor 2 subfamily with allergy and asthma after hospitalization for bronchiolitis in infancy. Pediatric Infect. Dis. J. 2014;33:463-466 https://doi: 10.1097/ INF.0000000000000253.
  5. Kormann M. S, Depner M., Hartl D., Klopp N., Illig T., Adamski J. Vogelberg C., Weiland S. K., von Mutius E., Kabesch M. Toll-like receptor heterodimer variants protect from childhood asthma. J. Allergy Clin. Immunol. 2008;122:86-92. https://doi: 10.1016/j.jaci.2008.04.039
  6. Tabas, I., Glass C. K. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science (80). 2013; 339:166-172. https:doi: 10.1126/ science.1230720
  7. Lau M.Y., Dharmage S.C., Burgess J.A., Win A.K., Lowe A.J., Lodge C., Perret J., Hui J., Thomas P.S., Morrison S., Giles G.G., Hopper J., Abramson M.J., Walters E.H., Matheson M.C. The interaction between farming/rural environment and TLR2, TLR4, TLR6 and CD14 genetic polymorphisms in relation to early-and late-onset asthma. Scientific Reports Published. Scientific Reports. 2017; 7: 1-9. https://doi: 10.1038/ srep43681.
  8. Bortolatto J., Borducchi E., Rodriguez D., Keller A.C., Faquim-Mauro E., Bortoluci K.R., Mucida D., Gomes E., Christ A., Schnyder-Candrian S., Schnyder B., Ryffel B., Russo M. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis. Clin Exp Allergy. 2008; 38: 1668-1679. https:// doi: 10.1111/j.1365-2222.2008.03036.x. Epub 2008 Jun 25.
  9. Texereau J., Chiche J.D., Taylor W., Choukroun G., Comba B., Mira J.P. The Importance of Toll-Like Receptor 2 Polymorphisms in Severe Infections. Clinical Infectious Diseases. 2005; 41: 408-415.

Copyright (c) 2019 Pharmarus Print Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies